Essex Investment Management CO LLC Amicus Therapeutics, Inc. Transaction History

Essex Investment Management CO LLC

$516 Million
Q4 2024

A detailed history of Essex Investment Management CO LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 231,214 shares of FOLD stock, worth $1.99 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

231,214

Previous 268,743 13.96%

Holding current value

$1.99 Million

Previous $2.87 Million 24.11%

% of portfolio

0.42%

Previous 0.54%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$9.36 - $12.01 $351,271 - $450,723	-37,529 Reduced 13.96%	231,214 $2.18 Million
Q3 2024 Oct 10, 2024	BUY	$9.55 - $12.09 $7,095 - $8,982	743 Added 0.28%	268,743 $2.87 Million
Q2 2024 Aug 12, 2024	BUY	$9.04 - $11.75 $2.42 Million - $3.15 Million	268,000 New	268,000 $2.66 Million
Q1 2021 May 12, 2021	SELL	$9.2 - $23.86 $1.44 Million - $3.74 Million	-156,676 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $367,273 - $678,650	-27,266 Reduced 14.82%	156,676 $3.62 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $743,649 - $916,725	-57,692 Reduced 23.88%	183,942 $2.6 Million
Q2 2020 Aug 04, 2020	BUY	$8.86 - $15.69 $2.14 Million - $3.79 Million	241,634 New	241,634 $3.64 Million
Q4 2018 Feb 06, 2019	SELL	$8.38 - $13.44 $995,451 - $1.6 Million	-118,789 Closed	0 $0
Q3 2018 Oct 16, 2018	SELL	$11.6 - $16.54 $24,499 - $34,932	-2,112 Reduced 1.75%	118,789 $1.44 Million
Q1 2018 Apr 26, 2018	SELL	$13.76 - $17.12 $61,644 - $76,697	-4,480 Reduced 3.57%	120,901 $1.82 Million
Q4 2017 Feb 05, 2018	SELL	$12.51 - $16.24 $444,205 - $576,649	-35,508 Reduced 22.07%	125,381 $1.8 Million
Q3 2017 Oct 30, 2017	BUY	$11.74 - $15.78 $1.89 Million - $2.54 Million	160,889	160,889 $2.43 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

283M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.41B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Account

Essex Investment Management CO LLC Amicus Therapeutics, Inc. Transaction History